MITOCHONDRIAL ANTIBODY AMA IFA IN DILUTIONS Test
Test Name: MITOCHONDRIAL ANTIBODY AMA IFA IN DILUTIONS Test
Components: Price: 680.0 AED
Sample Condition: 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred.
Report Delivery: Sample Daily by 11 am; Report Next day
Method: Immunofluorescence Assay
Test Type: Autoimmune disorders, Disorders of Liver
Doctor: Gastroenterologist
Test Department: IMMUNOPATHOLOGY
Pre Test Information: Overnight fasting is preferred.
Test Details
The Mitochondrial Antibody (AMA) IFA in Dilutions test is a laboratory test used to detect the presence of antibodies against mitochondria in a person’s blood. Mitochondria are small structures found in cells that are responsible for producing energy.
In certain autoimmune diseases, such as primary biliary cholangitis (PBC), the immune system mistakenly attacks the mitochondria in the body. The test involves diluting the patient’s blood serum and then exposing it to a substrate that contains mitochondria. If the patient has antibodies against mitochondria, they will bind to the mitochondria in the substrate. This binding can be visualized using a fluorescent dye or other detection methods.
The test is performed using an immunofluorescence assay (IFA) technique, which involves labeling the antibodies with a fluorescent marker to make them visible under a microscope. The dilutions of the patient’s serum allow for a more accurate detection of antibodies at different levels of concentration.
A positive result on the Mitochondrial Antibody (AMA) IFA in Dilutions test indicates the presence of antibodies against mitochondria, suggesting an autoimmune condition such as PBC. However, it is important to note that a positive result does not necessarily mean the patient has PBC, as these antibodies can also be found in other autoimmune diseases or even in healthy individuals.
Further diagnostic tests and evaluation by a healthcare professional are usually necessary to confirm the diagnosis and determine the appropriate treatment plan.
| Test Name | MITOCHONDRIAL ANTIBODY AMA IFA IN DILUTIONS Test |
|---|---|
| Components | |
| Price | 680.0 AED |
| Sample Condition | 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred. |
| Report Delivery | Sample Daily by 11 am; Report Next day |
| Method | Immunofluorescence Assay |
| Test type | Autoimmune disorders, Disorders of Liver |
| Doctor | Gastroenterologist |
| Test Department: | IMMUNOPATHOLOGY |
| Pre Test Information | Overnight fasting is preferred. |
| Test Details |
The Mitochondrial Antibody (AMA) IFA in Dilutions test is a laboratory test used to detect the presence of antibodies against mitochondria in a person’s blood. Mitochondria are small structures found in cells that are responsible for producing energy. In certain autoimmune diseases, such as primary biliary cholangitis (PBC), the immune system mistakenly attacks the mitochondria in the body. The test involves diluting the patient’s blood serum and then exposing it to a substrate that contains mitochondria. If the patient has antibodies against mitochondria, they will bind to the mitochondria in the substrate. This binding can be visualized using a fluorescent dye or other detection methods. The test is performed using an immunofluorescence assay (IFA) technique, which involves labeling the antibodies with a fluorescent marker to make them visible under a microscope. The dilutions of the patient’s serum allow for a more accurate detection of antibodies at different levels of concentration. A positive result on the Mitochondrial Antibody (AMA) IFA in Dilutions test indicates the presence of antibodies against mitochondria, suggesting an autoimmune condition such as PBC. However, it is important to note that a positive result does not necessarily mean the patient has PBC, as these antibodies can also be found in other autoimmune diseases or even in healthy individuals. Further diagnostic tests and evaluation by a healthcare professional are usually necessary to confirm the diagnosis and determine the appropriate treatment plan. |
